Friday, October 23, 2020
wellness India Expo
Home Tags Hari S Bhartia

Tag: Hari S Bhartia

Jubilant launches JUBI-R, its generic version of COVID-19 drug remdesivir in...

Jubilant Generics, a subsidiary of Jubilant Life Sciences has launched remdesivir for injection under the brand name ‘JUBI-R’ in the Indian market at a price of INR 4,700 per vial of 100 mg (lyophilized injection)........................

Jubilant signs agreement with Gilead for Remdesivir, a potential therapy for...

Jubilant Life Sciences Limited got the rights to register, manufacture and sell Gilead’s investigational drug, remdesivir, a potential therapy for Covid-19 in 127 countries including India.....................

Jubilant Life Sciences YoY revenue up by 21% at 9,111 crore

While the company recorded the year on year revenue growth up to 21 percent standing ar Rs 9,111 crore and EBITDA up by 14% to Rs 1,775 crore. The normalized PAT stood at Rs 855 crore. During the fourth quarter, revenue was Rs 2,386 crore and normalized PAT was at Rs 135 Crore................

Jubilant leverages its epigenetics edge through $180 million deal with Checkpoint...

In this recent deal sealed by Jubilant Biosys, it will out-license a family of patents covering compounds..